Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE | Arthritis and Rheumatism | 1992 | 3.6K |
Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor | Journal of Experimental Medicine | 1992 | 3.2K |
Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages | Journal of Immunology | 1992 | 2.1K |
The mechanism of action of cyclosporin A and FK506 | Trends in Immunology | 1992 | 1.9K |
The pathophysiology of tumor necrosis factors | Annual Review of Immunology | 1992 | 1.6K |
HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation | Tissue Antigens | 1992 | 1.5K |
Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells | Journal of Experimental Medicine | 1992 | 1.4K |
Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation | Journal of Experimental Medicine | 1992 | 1.4K |
The immune system evolved to discriminate infectious nonself from noninfectious self | Trends in Immunology | 1992 | 1K |
Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells | Journal of Experimental Medicine | 1992 | 1K |
Bcl-2 initiates a new category of oncogenes: regulators of cell death | Blood | 1992 | 983 |
Apoptosis and programmed cell death in immunity | Annual Review of Immunology | 1992 | 982 |
Two TNF receptors | Trends in Immunology | 1992 | 927 |
Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products | Blood | 1992 | 907 |
Immunological aspects of demyelinating diseases | Annual Review of Immunology | 1992 | 903 |
The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice | Journal of Experimental Medicine | 1992 | 885 |
Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages | Journal of Experimental Medicine | 1992 | 874 |
Preliminary criteria for classification of adult Still's disease | Journal of Rheumatology | 1992 | 867 |
The origin and function of tumor-associated macrophages | Trends in Immunology | 1992 | 861 |
Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population | Journal of Virology | 1992 | 850 |
Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene | Journal of Virology | 1992 | 818 |
Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals | Journal of Experimental Medicine | 1992 | 817 |
Activated microglia mediate neuronal cell injury via a nitric oxide mechanism | Journal of Immunology | 1992 | 800 |
GATA-binding transcription factors in hematopoietic cells | Blood | 1992 | 796 |
Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing | Journal of Experimental Medicine | 1992 | 749 |